Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
28.01
+0.40 (1.45%)
Apr 29, 2026, 2:25 PM CST

SHE:300204 Statistics

Total Valuation

SHE:300204 has a market cap or net worth of CNY 13.19 billion. The enterprise value is 13.13 billion.

Market Cap 13.19B
Enterprise Value 13.13B

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date Apr 28, 2026
Ex-Dividend Date n/a

Share Statistics

SHE:300204 has 477.77 million shares outstanding. The number of shares has decreased by -11.76% in one year.

Current Share Class 477.77M
Shares Outstanding 477.77M
Shares Change (YoY) -11.76%
Shares Change (QoQ) +2.93%
Owned by Insiders (%) 6.73%
Owned by Institutions (%) 25.66%
Float 275.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 64.69
PB Ratio 16.59
P/TBV Ratio 17.50
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -156.63
EV / Sales 64.41
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -60.06

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.15.

Current Ratio 2.00
Quick Ratio 1.34
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF -0.55
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -10.70% and return on invested capital (ROIC) is -10.32%.

Return on Equity (ROE) -10.70%
Return on Assets (ROA) -4.09%
Return on Invested Capital (ROIC) -10.32%
Return on Capital Employed (ROCE) -6.96%
Weighted Average Cost of Capital (WACC) 8.46%
Revenue Per Employee 414,462
Profits Per Employee -170,447
Employee Count 484
Asset Turnover 0.17
Inventory Turnover 2.02

Taxes

Income Tax -218,077
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +136.79% in the last 52 weeks. The beta is 0.78, so SHE:300204's price volatility has been lower than the market average.

Beta (5Y) 0.78
52-Week Price Change +136.79%
50-Day Moving Average 27.42
200-Day Moving Average 34.76
Relative Strength Index (RSI) 44.37
Average Volume (20 Days) 54,522,916

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:300204 had revenue of CNY 203.92 million and -83.86 million in losses. Loss per share was -0.20.

Revenue 203.92M
Gross Profit 157.37M
Operating Income -80.01M
Pretax Income -93.19M
Net Income -83.86M
EBITDA -55.60M
EBIT -80.01M
Loss Per Share -0.20
Full Income Statement

Balance Sheet

The company has 128.28 million in cash and 119.78 million in debt, giving a net cash position of 8.51 million or 0.02 per share.

Cash & Cash Equivalents 128.28M
Total Debt 119.78M
Net Cash 8.51M
Net Cash Per Share 0.02
Equity (Book Value) 794.92M
Book Value Per Share 1.92
Working Capital 131.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -130.31 million and capital expenditures -88.39 million, giving a free cash flow of -218.70 million.

Operating Cash Flow -130.31M
Capital Expenditures -88.39M
Depreciation & Amortization 24.41M
Net Borrowing 98.85M
Free Cash Flow -218.70M
FCF Per Share -0.46
Full Cash Flow Statement

Margins

Gross margin is 77.17%, with operating and profit margins of -39.24% and -41.12%.

Gross Margin 77.17%
Operating Margin -39.24%
Pretax Margin -45.70%
Profit Margin -41.12%
EBITDA Margin -27.26%
EBIT Margin -39.24%
FCF Margin n/a

Dividends & Yields

SHE:300204 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 11.76%
Shareholder Yield 11.76%
Earnings Yield -0.64%
FCF Yield -1.66%

Stock Splits

The last stock split was on May 5, 2016. It was a forward split with a ratio of 1.3995941.

Last Split Date May 5, 2016
Split Type Forward
Split Ratio 1.3995941

Scores

Altman Z-Score n/a
Piotroski F-Score 1